Juniper Pharm Inc (JNP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2003 | 03-2003 | 12-2002 | 09-2002 | 06-2002 | |
| Sales | 4,920 | 3,606 | 2,346 | 4,041 | 2,455 |
| Cost of Goods | 2,137 | 1,677 | 1,459 | 1,916 | 902 |
| Gross Profit | 2,782 | 1,928 | 887 | 2,124 | 1,553 |
| Operating Expenses | 6,928 | 6,999 | 7,812 | 4,673 | 3,092 |
| Operating Income | -4,008 | -4,393 | -6,466 | -1,633 | -637 |
| Interest Expense | 356 | 370 | 209 | 237 | 217 |
| Other Income | -3 | 59 | -59 | -9 | -4,001 |
| Pre-tax Income | -4,367 | -4,704 | -6,734 | -1,879 | -4,856 |
| Net Income Continuous | -4,367 | -4,704 | -6,734 | -1,879 | -4,856 |
| Net Income | $-4,367 | $-4,704 | $-6,734 | $-1,879 | $-4,856 |
| EPS Basic Total Ops | -0.96 | -1.04 | -1.68 | -0.40 | -1.12 |
| EPS Basic Continuous Ops | -0.98 | -1.06 | -1.53 | -0.43 | -1.14 |
| EPS Diluted Total Ops | -0.96 | -1.04 | -1.68 | -0.40 | -1.12 |
| EPS Diluted Continuous Ops | -0.98 | -1.06 | -1.53 | -0.43 | -1.14 |
| EBITDA(a) | $-3,884 | $-4,270 | $-6,342 | $-1,508 | $-472 |